Financial Consulate’s DexCom DXCM Stock Holding History

Financial Consulate’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29.2K	Hold	434	–	–	﹤0.01%	450
2026 Q1	$27.3K	Sell	434 -6	-1%	-$418	﹤0.01%	431
2025 Q4	$29.2K	Buy	440 +10	+2%	+$647	﹤0.01%	402
2025 Q3	$28.9K	Buy	+430	New	+$34K	﹤0.01%	394

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Financial Consulate's DXCM Position: Q2 2026 in Review

Financial Consulate held its DexCom (DXCM) position steady in Q2 2026 at 434 shares worth $29.2K. The position accounts for ﹤0.01% of the portfolio, ranked #450.

Financial Consulate first reported a position in DXCM in Q3 2025 and has held it in 4 quarters since. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Financial Consulate held 434 shares of DexCom worth $29.2K as of Q2 2026.
Financial Consulate left its DexCom share count unchanged in Q2 2026.
DexCom made up ﹤0.01% of Financial Consulate's portfolio in Q2 2026, its #450 holding.
Financial Consulate first reported a position in DexCom in Q3 2025 and has held it in 4 quarters since.
973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.